No, this is a treatment. Vaccines are preventative by priming your immune system, this directly targets SARS-CoV-2 itself, so is for people who actively have COVID.
"In conclusion, NTD-RBD bsAbs offer promising potential for the design of resilient, next-generation antibody therapeutics against SARS-CoV-2 VOCs."